MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$17,927K
EPS
-$0.17
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
13,606 28,563* 17,441 18,022
General and administrative
5,360 8,037* 5,091 5,451
Impairment charge
--6,350* -3,175
Total operating expenses
18,966 30,250 22,532 26,648
Loss from operations
-18,966 -30,250* -22,532 -26,648
Interest income
1,182 1,102* 802 1,106
Interest expense
331 383* 408 405
Other income (expense), net
188 -24* -6 -2
Loss before income taxes
--29,555* --
Income tax provision
-0* --
Net loss
-17,927 -29,555 -22,144 -25,949
Basic EPS
-0.17 -0.548 -0.41 -0.49
Diluted EPS
-0.17 -0.548 -0.41 -0.49
Basic Average Shares
104,573,657 53,952,500 53,577,066 53,445,631
Diluted Average Shares
104,573,657 53,952,500 53,577,066 53,445,631
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$17,927K Interest income$1,182K Other income(expense), net$188K Loss from operations-$18,966K Interest expense$331K Total operatingexpenses$18,966K Research and development$13,606K General andadministrative$5,360K

ALX ONCOLOGY HOLDINGS INC (ALXO)

ALX ONCOLOGY HOLDINGS INC (ALXO)